Sign in

CIK 0000926617

  • Non-accelerated filer
  • Smaller reporting company

Aspira Women's Health Inc.

Sign in to watch
Ticker
AWHL
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330595156
Phone
+1 512-519-0400
Business address
12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
Former names
VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 80 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-05-13 Hombeck Torsten Chief Financial Officer Grant or award · EMPLOYEE STOCK OPTION (RIGHT TO BUY) +22,000 22,000
2024-05-03 Hombeck Torsten Chief Financial Officer Grant or award · EMPLOYEE STOCK OPTION (RIGHT TO BUY) +6,667 $3.20 $21K 6,667
2024-02-14 Hombeck Torsten Chief Financial Officer Grant or award · Employee stock option (right to buy) +20,000 20,000
2023-11-17 Hombeck Torsten Chief Financial Officer Grant or award +30,000 33,000
2023-09-08 Hombeck Torsten Chief Financial Officer Purchase +2,246 $4.30 $10K 3,000
2023-07-25 Hombeck Torsten Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +13,334 13,334
2023-07-24 Hombeck Torsten Chief Financial Officer Purchase +754 $3.98 $3K 754

Page 1 of 1 · 7 trades